1. The Company has a process of identification of ‘suppliers’ registered under the Micro, Small and Medium Enterprises Development (‘MSMED’) Act, 2006, by obtaining confirmations from all suppliers. The Company has not received intimation from all the ‘suppliers’ regarding their status under MSMED Act, 2006 and hence disclosures if any, relating to amounts unpaid as at the yearend together with interest paid/payable as required have not been furnished.

2. In accordance with Accounting Standard-17 ‘Segment Reporting’, segment information has been given in the consolidated financial statements of Centrum Capital Limited, and therefore, no separate disclosure on segment information is given in these financial statements

3. Based on the financial estimates and business rationale provided by the management for its exposure in Centrum Infrastructure Advisory Limited (CIAL), Centrum Defence Systems Limited (CDSL) and Centrum Capital Holdings LLC (CCH LLC) confirming fair valuation higher than the cost of Investments of Rs, 5,00,00,000 (P.Y. Rs, 5,00,000) in CIAL, Rs, 3,00,00,000 (P.Y. Rs, 5,00,000) in CDSL and Rs, 1,94,28,125 (P.Y. Rs, 19,428,125) in CCH LLC the management believes that no impairment provision is required in respect of said Investments along with loans advanced amounting to Rs, 17,64,263 (P.Y.Rs, 2,89,64,263) to CIAL , Rs, Nil (P.Y. Rs, 1,83,12,831) to CDSL and Rs, 64,01,272 (P.Y. Rs, 63,91,455 ) to CCH LLC.

4. Other Income

A. During the previous year 2017, the company has sold 16,250 equity shares of its wholly owned subsidiary Buyforex India Limited (BIL) to its Step down subsidiary Centrum Direct Limited (CDL). During the current year, the company has sold the balance 33,750 equity shares of BIL and earned profit of Rs, 79,90,04,604 from this sale.

B. During the year the Company’s subsidiary, Centrum Retail Services Limited (CRSL) has sold its stake in its subsidiary viz. Centrum Direct Limited (CDL) to NYLIM Jacob Ballas India Holdings IV and Jacob Ballas Capital India Private Limited. The Company has received Rs, 22,53,14,291 towards its share of gain/profit on sale of said shares held by CRSL as per terms of agreement dated October 29, 2014. In the previous year, the Company has received Rs, 90,12,55,879 towards its share of gain/profit on sale of said shares held by CRSL as per terms of agreement as stated above.

5. During the year, the Company had issued 2,01,07,260 (Two Crore One Lakh Seven Thousand Two Hundred Sixty only) Warrants Convertible into Equity Shares, to the Promoter of the Company on preferential basis. Each Warrant is convertible into one equity share at a conversion price of Rs, 74.60 per share, including a premium of Rs, 73.60 on each share of Face Value of Rs, 1/-. The rights vested shall be exercised not later than 18 months from the date of allotment in accordance with the SEBI (ICDR) Regulations, 2015. The prospective allottees had paid Rs, 37,50,00,399 towards 25% value of total consideration payable for the Warrants. In case of non exercise of warrants within the period of 18 months, the same shall stand forfeited and the money received against the same shall not be refunded by the Company.

The details of Allottees of Warrants convertible into Equity Shares are as follows: -BG Advisory Services LLP. Rs, 2,01,07,260

As at 31st March 2018, 2,01,07,260 Warrants (Previous Year NIL) were pending to be converted into Equity Shares of Rs, 1/- each. The warrants would be converted into equivalent number of shares on payment of balance amount.

6. Managerial Remuneration

The company has paid a managerial remuneration in excess of the limits as laid down in the Section 197 read with Schedule V to the Act of Rs, 3,39,77,526/- during the financial year 2017-18 to its Executive Chairman. Since the payment of the remuneration is in excess of the limits, the Company made an application to the Central Government. The Central Government has partially allowed the excess remuneration and the Company has made a representation for the balance. The outcome of the same is awaited, pending which the balance amount is held in trust by the executive chairman and hence no adjustment has been made in the accounts.

7. Disclosure relating to CSR expenditure

Gross amount required to be spent by company towards Corporate Social responsibility during the year is Nil. (PY Rs, 17,26,940/-)

8. Prior Year Comparatives

The Figures for the previous year have been regrouped/ rearranged wherever necessary to conform to current year’s classification.